Cargando…
VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing
A significant number of fractures develop non‐union. Mesenchymal stem cell (MSC) therapy may be beneficial, however, this requires cell acquisition, culture and delivery. Endogenous mobilization of stem cells offers a non‐invasive alternative. The hypothesis was administration of VEGF and the CXCR4...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563072/ https://www.ncbi.nlm.nih.gov/pubmed/30345545 http://dx.doi.org/10.1002/jor.24164 |
_version_ | 1783426467553607680 |
---|---|
author | Meeson, Richard Sanghani‐Keri, Anita Coathup, Melanie Blunn, Gordon |
author_facet | Meeson, Richard Sanghani‐Keri, Anita Coathup, Melanie Blunn, Gordon |
author_sort | Meeson, Richard |
collection | PubMed |
description | A significant number of fractures develop non‐union. Mesenchymal stem cell (MSC) therapy may be beneficial, however, this requires cell acquisition, culture and delivery. Endogenous mobilization of stem cells offers a non‐invasive alternative. The hypothesis was administration of VEGF and the CXCR4 antagonist AMD3100 would increase the circulating pool of available MSCs and improve fracture healing. Ex‐breeder female wistar rats received VEGF followed by AMD3100, or sham PBS. Blood prepared for culture and colonies were counted. P3 cells were analyzed by flow cytometry, bi‐differentiation. The effect of mobilization on fracture healing was evaluated with 1.5 mm femoral osteotomy stabilized with an external fixator in 12–14 week old female Wistars. The mobilized group had significantly greater number of cfus/ml compared to controls, p = 0.029. The isolated cells expressed 1.8% CD34, 35% CD45, 61% CD29, 78% CD90, and differentiated into osteoblasts but not into adipocytes. The fracture gap in animals treated with VEGF and AMD3100 showed increased bone volume; 5.22 ± 1.7 µm(3) and trabecular thickness 0.05 ± 0.01 µm compared with control animals (4.3 ± 3.1 µm(3), 0.04 ± 0.01 µm, respectively). Radiographic scores quantifying fracture healing (RUST) showed that the animals in the mobilization group had a higher healing score compared to controls (9.6 vs. 7.7). Histologically, mobilization resulted in significantly lower group variability in bone formation (p = 0.032) and greater amounts of bone and less fibrous tissue than the control group. Clinical significance: This pre‐clinical study demonstrates a beneficial effect of endogenous MSC mobilization on fracture healing, which may have translation potential to prevent or treat clinical fractures at risk of delayed or non‐union fractures. © 2018 The Authors. Journal of Orthopaedic Research® Published by Wiley Periodicals, Inc. on behalf of Orthopaedic Research Society. J Orthop Res 37:1294–1302, 2019. |
format | Online Article Text |
id | pubmed-6563072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65630722019-06-17 VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing Meeson, Richard Sanghani‐Keri, Anita Coathup, Melanie Blunn, Gordon J Orthop Res Research Articles A significant number of fractures develop non‐union. Mesenchymal stem cell (MSC) therapy may be beneficial, however, this requires cell acquisition, culture and delivery. Endogenous mobilization of stem cells offers a non‐invasive alternative. The hypothesis was administration of VEGF and the CXCR4 antagonist AMD3100 would increase the circulating pool of available MSCs and improve fracture healing. Ex‐breeder female wistar rats received VEGF followed by AMD3100, or sham PBS. Blood prepared for culture and colonies were counted. P3 cells were analyzed by flow cytometry, bi‐differentiation. The effect of mobilization on fracture healing was evaluated with 1.5 mm femoral osteotomy stabilized with an external fixator in 12–14 week old female Wistars. The mobilized group had significantly greater number of cfus/ml compared to controls, p = 0.029. The isolated cells expressed 1.8% CD34, 35% CD45, 61% CD29, 78% CD90, and differentiated into osteoblasts but not into adipocytes. The fracture gap in animals treated with VEGF and AMD3100 showed increased bone volume; 5.22 ± 1.7 µm(3) and trabecular thickness 0.05 ± 0.01 µm compared with control animals (4.3 ± 3.1 µm(3), 0.04 ± 0.01 µm, respectively). Radiographic scores quantifying fracture healing (RUST) showed that the animals in the mobilization group had a higher healing score compared to controls (9.6 vs. 7.7). Histologically, mobilization resulted in significantly lower group variability in bone formation (p = 0.032) and greater amounts of bone and less fibrous tissue than the control group. Clinical significance: This pre‐clinical study demonstrates a beneficial effect of endogenous MSC mobilization on fracture healing, which may have translation potential to prevent or treat clinical fractures at risk of delayed or non‐union fractures. © 2018 The Authors. Journal of Orthopaedic Research® Published by Wiley Periodicals, Inc. on behalf of Orthopaedic Research Society. J Orthop Res 37:1294–1302, 2019. John Wiley and Sons Inc. 2018-11-30 2019-06 /pmc/articles/PMC6563072/ /pubmed/30345545 http://dx.doi.org/10.1002/jor.24164 Text en © 2018 The Authors. Journal of Orthopaedic Research1® Published by Wiley Periodicals, Inc. on behalf of Orthopaedic Research Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Meeson, Richard Sanghani‐Keri, Anita Coathup, Melanie Blunn, Gordon VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing |
title | VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing |
title_full | VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing |
title_fullStr | VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing |
title_full_unstemmed | VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing |
title_short | VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing |
title_sort | vegf with amd3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563072/ https://www.ncbi.nlm.nih.gov/pubmed/30345545 http://dx.doi.org/10.1002/jor.24164 |
work_keys_str_mv | AT meesonrichard vegfwithamd3100endogenouslymobilizesmesenchymalstemcellsandimprovesfracturehealing AT sanghanikerianita vegfwithamd3100endogenouslymobilizesmesenchymalstemcellsandimprovesfracturehealing AT coathupmelanie vegfwithamd3100endogenouslymobilizesmesenchymalstemcellsandimprovesfracturehealing AT blunngordon vegfwithamd3100endogenouslymobilizesmesenchymalstemcellsandimprovesfracturehealing |